Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Bloomera Receives Cultivation License from Health Canada

Bloomera
Posted on: 13 Nov 17

Bloomera (or the “Company”) is pleased to announce it has received its license to cultivate medical cannabis from Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Obtaining this license marks a significant milestone for Bloomera. The Company expects to begin cultivation at its facility in the coming weeks and then request a pre-sales inspection with Health Canada, the last stage prior to receiving an amendment to the license that enables sales of dried flower.

“This is a critical landmark for the Bloomera team and underscores the devotion and effort given by all involved,” said Joey Xu, Director of Bloomera. “It was a three year journey to get to this point and now we are looking forward to beginning production. Our focus – and the ethos of Bloomera – has always been and will be creating a positive impact on the lives of those whom we come in contact. We believe this starts with sourcing, curating, and cultivating outstanding genetics and ends with delivering excellent customer service and that’s exactly what we are going to do.”

Bloomera’s 20,000 sq. ft. state-of-the-art indoor facility is located only 30km from downtown Toronto, in Markham, serving as a prime distribution hub to the east coast and Canada’s most populous market (Greater Toronto Area). The facility is capable of producing over 2,000 kg of dried cannabis per year, and the Company is already working on extraction and R&D based strategies aimed at supporting the development of proprietary cannabis oil formulations and non-flower product types for both the medical and future adult-use market.

With the first facility licensed to cultivate, Bloomera is actively engaged in seeking a land package for the purposes of constructing a significantly larger dutch-style hybrid greenhouse that will serve as the foundation of the Company’s low cost production operations. Bloomera anticipates announcing further details on its current operations and second site expansion plan in the coming months.

“Our mission as a corporation is to educate people on the plant, its benefits and our brand. The Company is born from the same passion and imagination that guided the spirits of cannabis’ early innovators. Much like its owners, a diverse group who refuse to be defined by convention, Bloomera’s overall brand will be strong and sustainable globally,” said Wafik Abadir, Director.

Bloomera

Bloomera is a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company’s 20,000 sq. ft. state-of-the-art indoor facility is located 30km from downtown Toronto, in Markham, and is capable of producing over 2,000 kg of dried cannabis per year. Founded by a labour of love, Bloomera seeks to positively impact the lives of all those it contacts. The Company is taking a handcrafted approach to cultivating and producing beautiful cannabis products for medicinal patients and adult-users alike.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171113005949/en/

Business Wire
www.businesswire.com

Last updated on: 13/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.